(Q38118358)

29 August 2017

title

Liver diseases and aging: friends or foes? (English)

1 reference

29 August 2017

4

1 reference

29 August 2017

Fareeba Sheedfar

1

1 reference

29 August 2017

Stefano Di Biase

series ordinal

2

1 reference

29 August 2017

Debby Koonen

series ordinal

3

1 reference

29 August 2017

publication date

30 July 2013

1 reference

29 August 2017

1 reference

29 August 2017

volume

12

1 reference

29 August 2017

issue

6

1 reference

29 August 2017

page(s)

950-954

1 reference

Autophagy in nonalcoholic steatohepatitis

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Tumor necrosis factor receptor 1 gain-of-function mutation aggravates nonalcoholic fatty liver disease but does not cause insulin resistance in a murine model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Apolipoprotein E deficiency and a mouse model of accelerated liver aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Lifetime sedentary living accelerates some aspects of secondary aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Primary liver cancer: worldwide incidence and trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Synergism between smoking and alcohol consumption with respect to serum gamma-glutamyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Selective versus total insulin resistance: a pathogenic paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Non-alcoholic steatohepatitis and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Effect of a C/EBP gene replacement on mitochondrial biogenesis in fat cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Human fatty liver disease: old questions and new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Liver diseases in the elderly: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Aging promotes the development of diet-induced murine steatohepatitis but not steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Inflamm-aging. An evolutionary perspective on immunosenescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Chronic liver disease in an ageing population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Mechanisms and implications of age-related changes in the liver: nonalcoholic Fatty liver disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Role of β-adrenergic receptors in regulation of hepatic fat accumulation during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Franklin H. Epstein Lecture: Sirtuins, aging, and medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Benefits of lifestyle modification in NAFLD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Farnesoid X receptor inhibits gankyrin in mouse livers and prevents development of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

The age-associated decline of glycogen synthase kinase 3beta plays a critical role in the inhibition of liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

21 January 2018

GSK3beta and aging liver

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

The reduction of SIRT1 in livers of old mice leads to impaired body homeostasis and to inhibition of liver proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Increased expression of enzymes of triglyceride synthesis is essential for the development of hepatic steatosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Beta adrenergic regulation of rat liver glycogenolysis during aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Decreased nuclear beta-catenin, tau hyperphosphorylation and neurodegeneration in GSK-3beta conditional transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Galactose elimination capacity and liver volume in aging man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

The changing pattern of epidemiology in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Clinical and histological determinants of nonalcoholic steatohepatitis and advanced fibrosis in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Aging is associated with increased clonogenic potential in rat liver in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Mitochondrial dysfunction in the elderly: possible role in insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Redox homeostasis and epigenetics in non-alcoholic fatty liver disease (NAFLD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Immunopositivity for histone macroH2A1 isoforms marks steatosis-associated hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Liver disease in the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Aging, androgens, and the metabolic syndrome in a longitudinal study of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Lipotoxicity, overnutrition and energy metabolism in aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Replicative senescence: implications for in vivo aging and tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Dissociating fatty liver and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Fat tissue, aging, and cellular senescence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Insulin resistance, inflammation, and non-alcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Aging and liver regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

A metabolic signature predicts biological age in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Beneficial effects of subcutaneous fat transplantation on metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Influence of age and smoking on drug kinetics in man: studies using model compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP alpha growth inhibitory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

Role of HDAC1 in senescence, aging, and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

The effect of age upon liver volume and apparent liver blood flow in healthy man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FACEL.12128

21 January 2018

Identifiers

DOI

10.1111/ACEL.12128

1 reference

29 August 2017

1 reference